Arkolith/Insider Trading/OMIC/Form 4

Spaventa Andrew

Chief Executive Officer, DirectorSingular Genomics Systems, Inc. (OMIC) · full profile →Form 4 · filed Dec 17, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4K
Net Open-Market Flow
-$4K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 16, 2024Gift(G)306—$0142K
Dec 16, 2024Gift(G)306—$0325
Dec 16, 2024Sell(S)180$20.16$4K631
Dec 15, 2024Option exercise(M)486——811

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 15, 2024Option exercise(M)486—$04K

Transaction Codes

G
Gift
S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-137425) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML